Angelique K. Luabeya

University Of Cape Town
Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop.

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop.

Journal: Vaccine

Published: March 10, 2026

Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans.

Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans.

Journal: Frontiers in immunology

Published: May 31, 2024

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial.

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial.

Journal: The Lancet. Global health

Published: September 18, 2023

Preferences of health care workers using tongue swabs for tuberculosis diagnosis during COVID-19.

Preferences of health care workers using tongue swabs for tuberculosis diagnosis during COVID-19.

Journal: medRxiv : the preprint server for health sciences

Published: December 16, 2022

Preferences of healthcare workers using tongue swabs for tuberculosis diagnosis during COVID-19.

Preferences of healthcare workers using tongue swabs for tuberculosis diagnosis during COVID-19.

Journal: PLOS global public health

Published: December 05, 2022

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

Journal: The Lancet. Infectious diseases

Published: July 06, 2021

Sample adequacy controls for infectious disease diagnosis by oral swabbing.

Sample adequacy controls for infectious disease diagnosis by oral swabbing.

Journal: PloS one

Published: June 25, 2020

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.

Journal: The Lancet. Respiratory medicine

Published: November 05, 2019

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.

Journal: The Lancet. Respiratory medicine

Published: March 03, 2019

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.

Journal: American journal of respiratory and critical care medicine

Published: August 10, 2018

Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection.

Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection.

Journal: Frontiers in immunology

Published: March 13, 2018

Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.

Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.

Journal: PloS one

Published: May 26, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026